Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome result...
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
About this item
Full title
Author / Creator
Marso, Steven P., MD , Poulter, Neil R., FRCP , Nissen, Steven E., MD , Nauck, Michael A., MD , Zinman, Bernard, MD , Daniels, Gilbert H., MD , Pocock, Stuart, PhD , Steinberg, William M., MD , Bergenstal, Richard M., MD , Mann, Johannes F.E., MD , Ravn, Lasse Steen, MD, PhD , Frandsen, Kirstine Brown, MD , Moses, Alan C., MD and Buse, John B., MD, PhD
Publisher
United States: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Background Diabetes is a multisystem disorder associated with a nearly twofold excess risk for a broad range of adverse cardiovascular outcomes including coronary heart disease, stroke, and cardiovascular death. Liraglutide is a human glucagon-like peptide receptor analog approved for use in patients with type 2 diabetes mellitus (T2DM). Study Desi...
Alternative Titles
Full title
Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial
Authors, Artists and Contributors
Author / Creator
Poulter, Neil R., FRCP
Nissen, Steven E., MD
Nauck, Michael A., MD
Zinman, Bernard, MD
Daniels, Gilbert H., MD
Pocock, Stuart, PhD
Steinberg, William M., MD
Bergenstal, Richard M., MD
Mann, Johannes F.E., MD
Ravn, Lasse Steen, MD, PhD
Frandsen, Kirstine Brown, MD
Moses, Alan C., MD
Buse, John B., MD, PhD
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1448209536
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1448209536
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2013.07.012
